通策医疗(600763.SH)：2025年中报净利润为3.21亿元

Core Insights - The company Tongce Medical (600763.SH) reported a total revenue of 1.448 billion yuan and a net profit attributable to shareholders of 321 million yuan for the first half of 2025 [1] - The operating cash flow for the company was 356 million yuan [1] Financial Performance - The latest debt-to-asset ratio is 27.51%, which is an increase of 0.54 percentage points from the previous quarter [3] - The latest gross profit margin is 40.75%, down by 3.46 percentage points from the previous quarter and down by 0.08 percentage points year-on-year [3] - The return on equity (ROE) stands at 7.74%, a decrease of 0.13 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.72 yuan [3] - The total asset turnover ratio is 0.23 times [3] - The inventory turnover ratio is 28.10 times, which is a decrease of 5.27 times year-on-year, representing a decline of 15.78% [3] Shareholder Structure - The number of shareholders is 88,100, with the top ten shareholders holding a total of 209 million shares, accounting for 46.66% of the total share capital [3] - The largest shareholder is Hangzhou Baoqun Industrial Group Co., Ltd., holding 33.8% of the shares [3]